Scorpion is a clinical-stage, precision oncology company developing transformational targeted therapies for patients with cancer. We have built proprietary and fully-integrated discovery capabilities leveraging the most advanced technologies across cancer biology, medicinal chemistry and data sciences. Our current pipeline, led by our mutant-selective PI3Ka program STX-478, consists of three internally discovered clinical product candidates in addition to multiple discovery-stage programs. Our focus is on solving current gaps in therapeutic options for patients with cancer by discovering and developing exquisitely-selective product candidates against well-validated, previously undruggable targets to improve patient outcomes.
Company Details
- Employees
- 35
- Founded
- -
- Phone
- (212) 841-1015
- in****@****ntx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- scorpiontx.com
Scorpion Therapeutics Questions
Scorpion Therapeutics's helpline number is (212) 841-1015
Scorpion Therapeutics's website is scorpiontx.com
Scorpion Therapeutics's LinkedIn profile is https://www.linkedin.com/company/scorpiontherapeutics
Scorpion Therapeutics has
35 employees.
View email and phone details for 35
employees at Scorpion Therapeutics.
Scorpion Therapeutics's industry is
Biotechnology Research
Scorpion Therapeutics's top competitors are
Vertex Pharmaceuticals,
Antares Therapeutics,
Idrx,
Beam Therapeutics,
Odyssey Therapeutics,
Relay Therapeutics,
Eli Lilly And Company,
Arsenal Biosciences, Inc.,
Kymera Therapeutics,
Cardurion Pharmaceuticals.
Scorpion Therapeutics's support email address is info@scorpiontx.com
Scorpion Therapeutics's categories are Biotechnology Research
Scorpion Therapeutics's founding year is 2020
